Litera Firm Intelligence Business Unit Cements Strategic Partnership with Wilson Allen
29.6.2021 16:00:00 EEST | Business Wire | Press release
The Litera Firm Intelligence business unit, developer of the Foundation data platform, and Wilson Allen, a leading provider of software, services, and consulting expertise to help law firms manage the entire client engagement lifecycle, today announced a strategic partnership. The partnership formalizes Wilson Allen as a technical implementation partner for the Foundation Firm Intelligence platform.
The Foundation Firm Intelligence platform breaks down data silos, combining information from disparate systems like CRM, Time and Billing, HR, conflicts, and external sources to provide a strategic view of law firm clients, including what work a firm has done for a client, who did the work, and all the third parties involved.
As a Foundation services partner, Wilson Allen will assist firms with implementing the Firm Intelligence platform and with associated strategic consulting, integration services, and data management services as needed.
“We’ve talked to several firms who are moving beyond the acronym of CRM when implementing solutions to better understand their client relationships across the client and matter lifecycle. Firm intelligence fits into a larger definition of business development strategy,” explained Michael Warren, Vice President and head of Wilson Allen’s Client Development and Intake practice. “Helping these firms implement Foundation is a natural fit for Wilson Allen, given our deep experience advising law firms on how to leverage their systems and data for competitive advantage. The company’s client development practice assists firms with software selection, data strategy and data migration, software implementation, technology training and change management.
“We’re seeing a growing need for business development and CRM expertise as firms move to leverage their Firm Intelligence platform for strategic relationship management,” said Barry Solomon, Litera Vice President for the Firm Intelligence business unit. “We are thrilled to partner with Wilson Allen to lead these Foundation projects. Michael Warren and his team bring tremendous depth and breadth across the business development domain and other system data and processes required to accelerate the business of law.”
About Litera Firm Intelligence Business Unit
Litera is the leading provider of software for law firms and document-intensive organizations across the globe, helping them satisfy the demands of clients. Part of the Firm Intelligence business unit, Foundation enables large law firms to transform their disparate data about clients, matters, people, and parties into usable and actionable information. The Foundation data platform includes integrated applications for Experience Management, Expertise Location, and Strategic Relationship Management – leveraging firm knowledge to win new business, improve client service, and gain insight into both the business and practice of law.
https://www.litera.com/
About Wilson Allen
Wilson Allen offers software, consulting, and technical services that enable law firms and professional services organizations to achieve better business performance. The company partners with leading industry solution providers to help firms identify and win more business, manage risk, deliver profitable engagements, and develop and implement performance analytics to enable more strategic and profitable operations.
https://wilsonallen.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210629005602/en/
Contact information
Media
Litera, Firm Intelligence Business Unit
Nancy Baron
E: Nancy.Baron@FoundationSG.com
Wilson Allen
Matthew DeVoll
E: Matthew.Devoll@WilsonAllen.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ryan Expands UK Business Rates and Property Tax Capabilities with Acquisition of WYM Rating5.2.2026 10:00:00 EET | Press release
Ryan, a leading global tax services and software provider, is pleased to announce the acquisition of Williams Young McKaig Ltd, a specialized commercial property consultancy, and its specialist rating division, WYM Rating, based in Edinburgh. The acquisition establishes Ryan’s property tax and business rates presence in Scotland and expands the Firm’s ability to serve clients with complex commercial property portfolios across the United Kingdom. Founded in 2012 by Richard Williams, Don Young, and Billy McKaig, WYM Rating is recognized for its client-centered approach and deep expertise across commercial property advisory. The consultancy supports landlords, occupiers, and investors through practical, market-informed advice grounded in decades of hands-on experience. WYM Rating’s capabilities span three focus areas, closely aligning with Ryan’s capabilities: Business rates and property tax Commercial property advisory Occupier and lease advisory “WYM Rating brings exactly the kind of sp
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release
Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob
Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release
VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom